I am currently working in the laboratory of Dr. Karl Munger attempting to characterize the nature of the responses of normal human keratinocytes to the cytokines TNF-alpha and TRAIL. Through their respective receptors, these cytokines can alternately cause growth arrest or apoptosis, depending upon conditions. Dr. Munger's lab studies the effects of the human papillomavirus on cell cycle control. This virus, whose natural host is the keratinocyte, attempts to take over control of the cell by expressing proteins which interfere with regulation of the natural cycle of cell growth and division. This permits the virus to use cellular machinery to replicate its own viral genome at the expense of the cell itself. These viral proteins also have the effect of altering an infected cell's responses to the protective cytokines produced by the body to defend against just such an infection. Among these cytokines are TNF-alpha and TRAIL. At this point in my research, I have discovered that human keratinocytes exhibit a dramatic growth arrest in response to small amounts of TNF-alpha and TRAIL alone and an apoptotic response when these compounds are combined with protein synthesis inhibitor cycloheximide. In the second phase of my research I will transfect papillomavirus oncoproteins into keratinocytes in an attempt to recognize changes in the growth arrest and apoptotic responses to TNF-alpha and TRAIL. I also will characterize changes in mRNA expression and stability of some of the proteins involved in cell cycle control.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Unknown (K16)
Project #
5K16DE000275-11
Application #
6474600
Study Section
Project Start
2001-07-01
Project End
2002-06-30
Budget Start
Budget End
Support Year
11
Fiscal Year
2001
Total Cost
$208,185
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
McDermott, Nancy E; Chuang, Sung-Kiang; Woo, Valerie V et al. (2006) Maxillary sinus augmentation as a risk factor for implant failure. Int J Oral Maxillofac Implants 21:366-74
Chuang, S K; Cai, T; Douglass, C W et al. (2005) Frailty approach for the analysis of clustered failure time observations in dental research. J Dent Res 84:54-8
Chuang, S-K; Hatch, J P; Rugh, J et al. (2005) Multi-center randomized clinical trials in oral and maxillofacial surgery: modeling of fixed and random effects. Int J Oral Maxillofac Surg 34:341-4
Treister, Nathaniel S; Woo, Sook-Bin; O'Holleran, Eileen W et al. (2005) Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:721-31
Woo, Valerie V; Chuang, Sung-Kiang; Daher, Shadi et al. (2004) Dentoalveolar reconstructive procedures as a risk factor for implant failure. J Oral Maxillofac Surg 62:773-80
Halpern, Leslie R; Carter, Jeffrey B; Chuang, Sung-Kiang et al. (2003) A comparison of 2 consultation and treatment strategies to manage impacted third molars. J Oral Maxillofac Surg 61:779-84
Basile, John R; Eichten, Alexandra; Zacny, Valerie et al. (2003) NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes. Mol Cancer Res 1:262-70
McDermott, Nancy E; Chuang, Sung-Kiang; Woo, Valerie V et al. (2003) Complications of dental implants: identification, frequency, and associated risk factors. Int J Oral Maxillofac Implants 18:848-55
Chuang, S K; Tian, L; Wei, L J et al. (2002) Predicting dental implant survival by use of the marginal approach of the semi-parametric survival methods for clustered observations. J Dent Res 81:851-5
Chuang, S K; Wei, L J; Douglass, C W et al. (2002) Risk factors for dental implant failure: a strategy for the analysis of clustered failure-time observations. J Dent Res 81:572-7

Showing the most recent 10 out of 32 publications